PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
5.21%
Revenue growth of 5.21% vs. zero growth in Healthcare. Walter Schloss might still want to see if it can translate into profits.
8.31%
Gross profit growth of 8.31% while Healthcare median is zero. Walter Schloss might see a slight advantage that could be built upon.
25.60%
EBIT growth of 25.60% while Healthcare median is zero. Walter Schloss would see a marginal edge that could be expanded upon.
27.07%
Operating income growth of 27.07% while Healthcare median is zero. Walter Schloss might see a modest advantage that can expand.
40.70%
Net income growth of 40.70% while Healthcare median is zero. Walter Schloss might see potential if moderate gains can keep rising.
40.71%
EPS growth of 40.71% while Healthcare median is zero. Walter Schloss might see a slight edge that could compound over time.
40.71%
Diluted EPS growth of 40.71% while Healthcare median is zero. Walter Schloss might see a slight edge that could improve over time.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
51.58%
10Y CAGR of 51.58% while Healthcare median is zero. Walter Schloss might see a slight advantage that can compound over very long horizons.
-16.43%
Negative 5Y CAGR while Healthcare median is 0.00%. Seth Klarman would see if others are at least growing moderately, indicating a firm-specific problem.
39.52%
3Y CAGR of 39.52% while Healthcare median is zero. Walter Schloss might see a modest improvement overshadowing the broader sector’s stagnation.
-100.00%
Negative 10Y OCF/share CAGR while Healthcare median is 0.00%. Seth Klarman would suspect the firm is failing to keep pace with industry peers.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
146.54%
Net income/share CAGR of 146.54% while Healthcare median is zero. Walter Schloss might see a marginal edge that can grow if the firm invests wisely.
26.35%
Net income/share CAGR of 26.35% while Healthcare median is zero. Walter Schloss might see a modest advantage that can expand mid-term.
62.87%
3Y net income/share CAGR > 1.5x Healthcare median of 0.02%. Joel Greenblatt might see a recent surge from market share gains or cost synergy.
172.32%
Equity/share CAGR of 172.32% while Healthcare median is zero. Walter Schloss might see a modest advantage in net worth accumulation that could matter long term.
21.13%
5Y equity/share CAGR near Healthcare median. Charlie Munger finds it normal mid-term expansion for the industry.
67.38%
3Y equity/share CAGR > 1.5x Healthcare median of 7.66%. Joel Greenblatt sees strong short-term returns on equity fueling net worth growth.
-25.00%
Dividend declines over 10 years while Healthcare median is 0.00%. Seth Klarman would see a relative disadvantage if peers consistently raised payouts.
50.00%
5Y dividend/share CAGR of 50.00% while Healthcare is zero. Walter Schloss sees at least some improvement that could compound over time.
38.46%
3Y dividend/share CAGR of 38.46% while Healthcare is zero. Walter Schloss sees a slight advantage if the firm is at least inching up payouts.
23035.00%
AR growth of 23035.00% while Healthcare median is zero. Walter Schloss checks if the difference points to new credit strategy or stronger sales push.
10.52%
Inventory growth of 10.52% while Healthcare median is zero. Walter Schloss checks if we’re preparing for a sales push or risking overstock.
6.02%
Asset growth of 6.02% while Healthcare median is zero. Walter Schloss sees a slight advantage if expansions yield good returns on capital.
5.55%
BV/share growth of 5.55% while Healthcare is zero. Walter Schloss sees a slight lead that can expand if sustained over time.
1.97%
Debt growth of 1.97% while Healthcare median is zero. Walter Schloss might see a modest difference that matters if interest coverage is tight.
No Data
No Data available this quarter, please select a different quarter.
-46.41%
SG&A decline while Healthcare grows. Seth Klarman sees potential cost advantage or a risk if it hurts future growth.